REG - UPL Limited - Financial Results March, 2024

UPLAnnouncement

13/05/2024 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240513:nRSM1806Oa&default-theme=true

RNS Number : 1806O  UPL Limited  13 May 2024

UPL LIMITED

 

 

Sub:

1.   Audited Standalone and Consolidated Financial Results for the quarter
and financial year ended 31(st) March 2024 and recommendation of dividend.

2.   Press Release.

3.   Investor Presentation.

 

Dear Sir/Madam,

 

The Board of Directors of the Company ("Board") held today i.e. Monday, 13(th)
May 2024, has considered and approved the audited standalone and consolidated
financial results of the Company for the quarter and financial year ended
31(st) March 2024.

The Board has recommended a dividend of 50% i.e. Rs. 1/- per equity share on
equity shares of Rs. 2/-each, subject to approval of members at the ensuing
Annual General Meeting.

The links for Financial results, Press Release and Investor Presentation is
mentioned below:-

 

Links:

 

1.   Financials: -

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/07dfaeda-90fc-4abf-9ad5-9e486343b528.pdf
(https://www.bseindia.com/xml-data/corpfiling/AttachLive/07dfaeda-90fc-4abf-9ad5-9e486343b528.pdf)

 

2.   Press Release:-

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/8e040859-fc76-4fc4-abb3-9df3a6dc3f85.pdf
(https://www.bseindia.com/xml-data/corpfiling/AttachLive/8e040859-fc76-4fc4-abb3-9df3a6dc3f85.pdf)

 

 

3.   Investor Presentation:-

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/7787d180-84ec-4ab9-94ed-b7a0c0d7bad1.pdf
(https://www.bseindia.com/xml-data/corpfiling/AttachLive/7787d180-84ec-4ab9-94ed-b7a0c0d7bad1.pdf)

 

We request you to take note of the same.

 

Thanking you,

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CIRUORRRSBUVAAR